Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Link Pharma Chem's
Operating Income
for the
three
months ended in Mar. 2026 was ₹-4.8 Mil. Link Pharma Chem's Interest Expense for the
three
months ended in Mar. 2026 was ₹-1.5 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Link Pharma Chem's Interest Coverage or its related term are showing as below:
BOM:524748'
s Interest Coverage Range Over the Past 10 Years
Min: 0.87 Med: 4.42 Max: 7.82
Current: 0.87
BOM:524748's Interest Coverage is ranked worse than 94.82% of 1235
companies
in the Chemicals industry
Industry Median: 10.26
vs BOM:524748: 0.87
Link Pharma Chem (BOM:524748) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Link Pharma Chem Interest Coverage Related Terms
Link Pharma Chem Interest Coverage Historical Data
* Premium members only.
The historical data trend for Link Pharma Chem's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Chemicals subindustry, Link Pharma Chem's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Link Pharma Chem Interest Coverage vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Link Pharma Chem's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Link Pharma Chem's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Link Pharma Chem did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Link Pharma Chem (BOM:524748) has a Interest Coverage of 0 (At Loss) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Link Pharma Chem and its competitors. Over the past decade, Link Pharma Chem's Interest Coverage has ranged from 0.87 to 7.82. According to the industry distribution chart, Link Pharma Chem ranks #1171 out of 1235 companies in the Chemicals industry, placing it in the top 94.8%.
Is Link Pharma Chem's Interest Coverage too high?
Link Pharma Chem's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 0.87 to a high of 7.82. Based on the distribution chart, Link Pharma Chem ranks #1171 out of 1235 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Link Pharma Chem has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Link Pharma Chem's Interest Coverage compare to DOW?
According to the Chemicals industry distribution chart, Link Pharma Chem ranks #1171 out of 1235 companies for Interest Coverage. This places Link Pharma Chem in the lower half of its industry. The industry median Interest Coverage is 10.26. Historically, Link Pharma Chem's own Interest Coverage has ranged from 0.87 to 7.82 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Chemicals company?
The median Interest Coverage among Chemicals companies is 10.26, based on 1,235 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Link Pharma Chem and its competitors. For the Chemicals industry, the median Interest Coverage is 10.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Link Pharma Chem's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Link Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Link Pharma Chem (BOM:524748) is currently considered Possible Value Trap. The stock's GF Value™ is ₹36.15, compared to a current price of ₹25.00 — trading 30.8% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Link Pharma Chem's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Link Pharma Chem (BOM:524748), the current Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Link Pharma Chem (BOM:524748) Overvalued in 2026?
Based on GuruFocus' analysis, Link Pharma Chem stock appears to be undervalued.
The current stock price of ₹25.00 is trading 30.8% below its estimated GF Value™ of ₹36.15.
GuruFocus considers Link Pharma Chem to be Possible Value Trap.
Key valuation signals for BOM:524748:
Interest Coverage: 0 (At Loss)
GF Value™: ₹36.15 vs. price of ₹25.00 (30.8% below fair value)
No single metric tells the full story. See the BOM:524748 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Link Pharma Chem Ltd is engaged in the manufacturing and selling of organic intermediates which are used in pharmaceuticals, agro and speciality chemical industries. The company has its manufacturing location at Nandesari in Gujarat. It operates through single segment which is Chemical manufacturing and generates revenue from the same. The company generates the majority of its revenue from domestic sales.
60GF Score
Get the complete analysis for BOM:524748
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524748 has been successfully added to your 
